In the multivariate Cox regression model, our data further confirmed that the expression of LMNB2 was still associated with the OS of patients with CRC (P = 0.007) and DFS (P = 0.012) as independent and meaningful prognostic biomarkers (Additoonal File 4 Table S4). This evidence concerns the gene LMNB2 and colorectal carcinoma.